Ranbaxy Laboratories Profile
Key Indicators
- Authorised Capital ₹ 300.00 Cr
- Paid Up Capital ₹ 212.83 Cr
- Company Age 63 Year, 7 Months
- Last Filing with ROC 31 Mar 2014
- Satisfied Charges ₹ 23.05 Cr
About Ranbaxy Laboratories
Company Details
- Location
Rupnagar, Punjab, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
L24231PB1961PLC003747
- Company No.
003747
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
16 Jun 1961
- Date of AGM
28 Jul 2014
- Date of Balance Sheet
31 Mar 2014
- Listing Status
Listed
- ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Ranbaxy Laboratories?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sushil Patawari  | Company Secretary | 21-Sep-1995 | Current |
| Arun Sawhney | Managing Director | 09-May-2011 | Current |
Board Members (7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Percy Shroff | Director | 27-Mar-2009 | Current |
| Rajesh Shah | Director | 29-May-2009 | Current |
Takashi Shoda  | Director | 19-Dec-2008 | Current |
| Akihiro Watanabe | Director | 09-May-2011 | Current |
| Tsutomu Une | Director | 10-May-2010 | Current |
Anthony Wild  | Director | 09-May-2011 | Current |
Financial Performance of Ranbaxy Laboratories.
Enhance accessibility to Ranbaxy Laboratories's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Ranbaxy Laboratories?
Unlock access to Ranbaxy Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Granules India LimitedArun Sawhney is a mutual person
Theia Ventures LlpRajesh Shah is a mutual person
- Amar Jyoti Agro Co Pvt Ltd
Rajesh Shah is a mutual person
- Amivir Agro Co Pvt Ltd
Rajesh Shah is a mutual person
- Sunnydays Agro Company Private Limited
Rajesh Shah is a mutual person
- Anant Jeewan Agro Co Pvt Ltd
Rajesh Shah is a mutual person
Charges (Loans)
₹0
₹23.05 Cr
Charges Breakdown by Lending Institutions
- Bank Of America : 23.05 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jul 1994 | Bank Of America | ₹23.05 Cr | Satisfied |
How Many Employees Work at Ranbaxy Laboratories?
Ranbaxy Laboratories has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ranbaxy Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ranbaxy Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
